Prof. Dr. Rafael Franco is a Professor of Biochemistry and Molecular Biology at the Department of Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, Spain. He obtained an M.Sc. in Chemistry/Biochemistry and a PhD on Membrane Proteins in the CNS at the University of Barcelona in 1978 and 1982, respectively. He was a Postdoc at the University College of London and Max Planck Institute of Molecular Physiology. He won the City of Barcelona Award for Biomedical Research in 1989. He is a member of the Biochemical Society, American Association for Pharmacology and Experimental Therapeutics, American Society for Biochemistry and Molecular Biology, and American Society for Neuroscience. His research field covers the regulation of cell, organ, and system functions by hormones.

Claudia Garrigos is a PhD student in Biomedicine at the University of Barcelona, specifically in the Rafael Franco and Gemma Navarro group. She was a graduate student in Biology at the University of Alicante (2018–2022). In 2016, she studied for a whole academic year in Westside High School in Augusta, GA, United States of America (USA). Moreover, she studied in Neuroscience courses for 6 months at the University of Skövde in Sweden (2021). She has experience in laboratory work from the Institute of Neuroscience, a joint center of the Spanish Research Council (CSIC) and the Miguel Hernández University (UMH) in Alicante. She gained experience in a research group involved in the "Altered molecular mechanisms in Alzheimer's disease" (2022). Furthermore, she obtained a Master's degree in Biomedicine at the University of Barcelona (2022–2023), specializing in the area of Human Pathology.

Dr. Jaume Lillo is an Academic Researcher at the Department of Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, Spain. Dr. Lillo is also affiliated with CiberNed, the Network Center for Neurodegenerative Diseases, and the Spanish National Health Institute Carlos III, Madrid, Spain. Dr. Lillo mainly focuses on unveiling the mechanisms implicated in neurodegeneration, including epigenetics and drug addiction. He is also interested in the validation of new pharmacological targets using small molecules. Dr. Lillo has greatly contributed to research in the following topics: Receptor, Cannabinoid, G protein-coupled receptor, Cannabinoid receptor, and Medicine.